NTRK1 and neoplasm: The SPRY (Sprouty) protein is an important inhibitor of receptor tyrosine kinase (RTK)-dependent signaling pathways and is found in several tumor types, such as prostate cancer, lung cancer, colon cancer, lymphoma, and thyroid cancer.